Johan Nilvebrant
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
-
- Glycosylation and Glycoproteins Research 22
- Protein purification and stability 13
- Biochemical and Structural Characterization 4
- vaccines and immunoinformatics approaches 3
-
- Monoclonal and Polyclonal Antibodies Research 33
- Co-authors
- Sophia Hober (14 shared papers)John Löfblom (5 shared papers)Johan Rockberg (3 shared papers)Per‐Åke Nygren (14 shared papers)Sachdev S. Sidhu (6 shared papers)Tove Alm (4 shared papers)Diana Spiegelberg (3 shared papers)Fredrik Lehmann (4 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Visualized Experiments (2 papers)Journal of Molecular Biology (2 papers)Organic & Biomolecular Chemistry (1 paper)Pharmaceutics (1 paper)
- Partner nations
- SwedenCanadaUnited States
In The Last Decade
Johan Nilvebrant
41 papers receiving 717 citations
Peers
Comparison fields: 5 of 63
- Radiology, Nuclear Medicine and Imaging 420
- Oncology 220
- Molecular Biology 416
- Immunology 89
- Biotechnology 33
Countries citing papers authored by Johan Nilvebrant
This map shows the geographic impact of Johan Nilvebrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Nilvebrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Nilvebrant more than expected).
Fields of papers citing papers by Johan Nilvebrant
This network shows the impact of papers produced by Johan Nilvebrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Nilvebrant. The network helps show where Johan Nilvebrant may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan Nilvebrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 93 | |
| 2 | 2021 | 56 | |
| 3 | 2015 | 53 | |
| 4 | 2014 | 50 | |
| 5 | 2018 | 38 | |
| 6 | 2011 | 37 | |
| 7 | 2019 | 35 | |
| 8 | 2010 | 29 | |
| 9 | 2013 | 27 | |
| 10 | 2012 | 26 | |
| 11 | 2016 | 26 | |
| 12 | 2018 | 24 | |
| 13 | 2017 | 22 | |
| 14 | 2018 | 22 | |
| 15 | 2017 | 21 | |
| 16 | 2014 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2015 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2018 | 12 |
About Johan Nilvebrant
Johan Nilvebrant is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Organic Chemistry, having authored 44 papers that have together received 728 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (33 papers), Glycosylation and Glycoproteins Research (22 papers), Protein purification and stability (13 papers), Biochemical and Structural Characterization (4 papers), Peptidase Inhibition and Analysis (4 papers), Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (3 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (420 citations), Oncology (220 citations), Molecular Biology (416 citations), Immunology (89 citations) and Biotechnology (33 citations). Johan Nilvebrant has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Sophia Hober, John Löfblom, Johan Rockberg, Per‐Åke Nygren, Sachdev S. Sidhu, Tove Alm, Diana Spiegelberg, Fredrik Lehmann, Marika Nestor and Sarah Lindbo. Their work appears in journals such as PLoS ONE, Journal of Visualized Experiments, Journal of Molecular Biology, Organic & Biomolecular Chemistry and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.